Cocrystal Pharma, Inc.COCPNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank47
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-9.68M
↑ 64% vs avg
Percentile
P47
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-26.75M
Historical baseline
PeriodValueYoY Change
TTM$-9.68M+45.5%
2024$-17.75M+15.3%
2023$-20.97M-16.8%
2022$-17.95M-27.9%
2021$-14.03M-48.8%
2020$-9.43M-327.6%
2019$-2.21M+96.5%
2018$-62.52M-745.8%
2017$-7.39M+93.0%
2016$-105.62M-